We are live on ! Find out more
CBT

CoreFirst Bank & Trust Portfolio holdings

AUM $189M
1-Year Est. Return 19.48%
This Fund
S&P 500
This Quarter Est. Return
-8.83%
1 Year Est. Return
+19.48%
3 Year Est. Return
+53.44%
5 Year Est. Return
+76.29%
10 Year Est. Return
AUM
$127M
AUM Growth
-$19.6M
Cap. Flow
-$4.58M
Cap. Flow %
-3.62%
Top 10 Hldgs %
35.93%
Holding
445
New
52
Increased
67
Reduced
88
Closed
49

Top Buys

Rank Stock Value
1
WBD icon
Warner Bros
WBD
+$501K
2
GE icon
GE Aerospace
GE
+$415K
3
JNJ icon
Johnson & Johnson
JNJ
+$389K
4
WMT icon
Walmart Inc
WMT
+$237K
5
UNP icon
Union Pacific
UNP
+$203K

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$1.26M
2
ARKK icon
ARK Innovation ETF
ARKK
+$521K
3
F icon
Ford
F
+$428K
4
AAPL icon
Apple
AAPL
+$406K
5
ARKG icon
ARK Genomic Revolution ETF
ARKG
+$406K

Sector Composition

Rank Sector Weight
1 Consumer Staples 20.56%
2 Technology 15.76%
3 Healthcare 13.8%
4 Consumer Discretionary 8.7%
5 Industrials 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
26
Bristol-Myers Squibb
BMY
$130B
$1.07M 0.85%
13,919
+2,000
+17% +$152K
PM icon
27
Philip Morris
PM
$313B
$1.05M 0.83%
10,600
-1
-0% -$102
DIS icon
28
Walt Disney
DIS
$171B
$1.03M 0.81%
10,869
-700
-6% -$77.7K
AMGN icon
29
Amgen
AMGN
$211B
$953K 0.75%
3,917
-487
-11% -$119K
MO icon
30
Altria Group
MO
$126B
$953K 0.75%
22,823
-5
-0% -$259
ABBV icon
31
AbbVie
ABBV
$471B
$932K 0.74%
6,088
-120
-2% -$18.3K
CAT icon
32
Caterpillar
CAT
$361B
$928K 0.73%
5,190
+315
+6% +$66.4K
IBM icon
33
IBM
IBM
$214B
$921K 0.73%
6,525
-504
-7% -$68K
TXN icon
34
Texas Instruments
TXN
$251B
$910K 0.72%
5,924
+220
+4% +$37K
RTX icon
35
RTX Corp
RTX
$295B
$836K 0.66%
8,693
+533
+7% +$51.2K
V icon
36
Visa
V
$703B
$811K 0.64%
4,119
-756
-16% -$156K
ETN icon
37
Eaton
ETN
$141B
$807K 0.64%
6,412
-476
-7% -$66.6K
ACN icon
38
Accenture
ACN
$106B
$793K 0.63%
2,855
DHR icon
39
Danaher
DHR
$140B
$764K 0.6%
3,400
-225
-6% -$51.8K
WFC icon
40
Wells Fargo
WFC
$257B
$729K 0.58%
18,615
-2,964
-14% -$130K
BRK.B icon
41
Berkshire Hathaway Class B
BRK.B
$1.1T
$655K 0.52%
2,398
-725
-23% -$227K
CI icon
42
Cigna
CI
$78.8B
$645K 0.51%
2,448
-1,243
-34% -$320K
AMZN icon
43
Amazon
AMZN
$2.47T
$635K 0.5%
5,980
+200
+3% +$25K
CSCO icon
44
Cisco
CSCO
$450B
$629K 0.5%
14,755
+268
+2% +$12.8K
UNP icon
45
Union Pacific
UNP
$174B
$584K 0.46%
2,739
+891
+48% +$203K
D icon
46
Dominion Energy
D
$62.1B
$574K 0.45%
7,193
-217
-3% -$17.9K
GOOG icon
47
Alphabet (Google) Class C
GOOG
$4.11T
$573K 0.45%
5,240
SPGI icon
48
S&P Global
SPGI
$124B
$573K 0.45%
1,701
-38
-2% -$13.5K
FISV
49
Fiserv Inc
FISV
$29.7B
$569K 0.45%
6,400
DE icon
50
Deere & Co
DE
$167B
$563K 0.44%
1,880
+400
+27% +$147K

Similar funds

CoreFirst Bank & Trust's Q2 2022 Portfolio in Review

As of Q2 2022, CoreFirst Bank & Trust held 445 positions worth $127M, down 13% from $146M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

CoreFirst Bank & Trust withdrew a net $4.58M in Q2 2022, closing 49 positions and reducing 88 holdings. Its most notable exit was ARK Genomic Revolution ETF, an estimated $406K position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 21% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.

Against the trend, CoreFirst Bank & Trust opened a new position in Warner Bros worth $362K.

  • CoreFirst Bank & Trust's largest Q2 2022 buy was Warner Bros: 27,003 shares worth $362K.
  • CoreFirst Bank & Trust added most to Johnson & Johnson in Q2 2022, an estimated $389K increase.
  • CoreFirst Bank & Trust's biggest Q2 2022 reduction was AT&T, cutting an estimated $1.26M.
  • CoreFirst Bank & Trust fully exited ARK Genomic Revolution ETF in Q2 2022, selling an estimated $406K.
  • CoreFirst Bank & Trust's ten largest holdings make up 36% of its $127M portfolio in Q2 2022.
  • CoreFirst Bank & Trust opened 52 new positions and closed 49 in Q2 2022.
  • CoreFirst Bank & Trust's portfolio value fell 13% quarter-over-quarter to $127M.

Based on CoreFirst Bank & Trust's 13F filing for Q2 2022, filed 16 Aug 2022.